Clinical trial
Abciximab for Prevention of Stroke Recurrence Before Endarterectomy in…
NCT00126139 · University of Zurich, Other · Terminated
Key facts
| NCT number | NCT00126139 |
|---|---|
| Title | Abciximab for Prevention of Stroke Recurrence Before Endarterectomy in Symptomatic Carotid Stenosis |
| Official title | Abciximab Versus Aspirin for Prevention of Stroke Recurrence Before Endarterectomy in Symptomatic >50% Carotid Stenosis: A Pilot Study (ASTERICS) |
| Lead sponsor | University of Zurich, Other |
| Collaborators | Schweizerische Herzstiftung Eli Lilly and Company Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Stroke, Stenosis |
| Intervention type | Drug |
| Interventions | Abciximab |
| Enrollment | 100 |
| Start date | Apr 1, 2004 |
| Completion | May 1, 2005 |
| First posted | Aug 2, 2005 |
| Last update posted | May 3, 2007 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: